Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
9.27
-0.01 (-0.11%)
At close: Jun 27, 2025, 11:21 AM
-0.11% (1D)
| Bid | 6.64 |
| Market Cap | 580.2M |
| Revenue (ttm) | 47.4M |
| Net Income (ttm) | -354.4M |
| EPS (ttm) | -5.8 |
| PE Ratio (ttm) | -1.6 |
| Forward PE | -3.36 |
| Analyst | Hold |
| Ask | 11.9 |
| Volume | 246,054 |
| Avg. Volume (20D) | 1,511,472 |
| Open | 9.26 |
| Previous Close | 9.28 |
| Day's Range | 9.20 - 9.28 |
| 52-Week Range | 4.62 - 13.47 |
| Beta | 0.17 |
About SAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Sage Therapeutics Inc. is scheduled to release its earnings on Jul 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+35.37%
Sage Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
+35.14%
Sage Therapeutics shares are trading higher after the company confirmed the receipt of an unsolicited, nonbinding proposal from Biogen to acquire all outstanding shares not already owned by Biogen for $7.22 per share.
